Global Peptic Ulcers Treatment Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-04-23
- Report ID: 105861
- Pages: 109
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Peptic Ulcers Treatment market in this environment.
In terms of revenue, this research report indicated that the global Peptic Ulcers Treatment market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Peptic Ulcers Treatment industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Ache Laboratorios Farmaceuticos S/A aims at producing XX K Units Peptic Ulcers Treatment in 2020, with XX % production to take place in global market, Astellas Pharma Inc. accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Peptic Ulcers Treatment Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Peptic Ulcers Treatment Market
Ache Laboratorios Farmaceuticos S/A
Astellas Pharma Inc.
ChoDang Pharm Co., Ltd.
Daewoong Pharmaceutical Co., Ltd.
Kukje Pharmaceutical Industry Co., Ltd.
RaQualia Pharma Inc.
Sequella, Inc.
Sihuan Pharmaceutical Holdings Group Ltd.
Sinil Pharmaceutical Co., Ltd
Yooyoung Pharmaceutical Co., Ltd
...
Major Type of Peptic Ulcers Treatment Covered in Prudent Markets report:
ASP-6537
BGC-001
DWJ-206
DWP-14012
Others
Application Segments Covered in Prudent Markets Market
Hospital
Clinic
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Peptic Ulcers Treatment Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 ASP-6537 -Product Introduction and Major Manufacturers
1.1.2 BGC-001 -Product Introduction and Major Manufacturers
1.1.3 DWJ-206 -Product Introduction and Major Manufacturers
1.1.4 DWP-14012 -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Peptic Ulcers Treatment Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Peptic Ulcers Treatment Market
3.1.1 Top Companies leading Peptic Ulcers Treatment Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Peptic Ulcers Treatment Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Peptic Ulcers Treatment Market
3.2.1 Top Companies leading Peptic Ulcers Treatment Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Peptic Ulcers Treatment Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Peptic Ulcers Treatment Market
3.3.1 Top Companies leading Peptic Ulcers Treatment Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Peptic Ulcers Treatment Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Peptic Ulcers Treatment Market
3.4.1 Top Companies leading Peptic Ulcers Treatment Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Peptic Ulcers Treatment Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Peptic Ulcers Treatment Market
3.5.1 Top Companies leading Peptic Ulcers Treatment Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Peptic Ulcers Treatment Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Peptic Ulcers Treatment Market
3.6.1 Top Companies leading Peptic Ulcers Treatment Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Peptic Ulcers Treatment Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Peptic Ulcers Treatment Market
3.7.1 Top Companies leading Peptic Ulcers Treatment Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Peptic Ulcers Treatment Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Peptic Ulcers Treatment Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Peptic Ulcers Treatment Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Peptic Ulcers Treatment Sales and Growth Rate (2021-2027)
5.2 Global Peptic Ulcers Treatment Sales Value and Growth Rate (2021-2027)
6 Peptic Ulcers Treatment Competitive Analysis
6.1 Ache Laboratorios Farmaceuticos S/A
6.1.1 Ache Laboratorios Farmaceuticos S/A Company Profiles
6.1.2 Ache Laboratorios Farmaceuticos S/A Product Introduction
6.1.3 Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Astellas Pharma Inc.
6.2.1 Astellas Pharma Inc. Company Profiles
6.2.2 Astellas Pharma Inc. Product Introduction
6.2.3 Astellas Pharma Inc. Peptic Ulcers Treatment Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 ChoDang Pharm Co., Ltd.
6.3.1 ChoDang Pharm Co., Ltd. Company Profiles
6.3.2 ChoDang Pharm Co., Ltd. Product Introduction
6.3.3 ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Daewoong Pharmaceutical Co., Ltd.
6.4.1 Daewoong Pharmaceutical Co., Ltd. Company Profiles
6.4.2 Daewoong Pharmaceutical Co., Ltd. Product Introduction
6.4.3 Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Kukje Pharmaceutical Industry Co., Ltd.
6.5.1 Kukje Pharmaceutical Industry Co., Ltd. Company Profiles
6.5.2 Kukje Pharmaceutical Industry Co., Ltd. Product Introduction
6.5.3 Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 RaQualia Pharma Inc.
6.6.1 RaQualia Pharma Inc. Company Profiles
6.6.2 RaQualia Pharma Inc. Product Introduction
6.6.3 RaQualia Pharma Inc. Peptic Ulcers Treatment Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Sequella, Inc.
6.7.1 Sequella, Inc. Company Profiles
6.7.2 Sequella, Inc. Product Introduction
6.7.3 Sequella, Inc. Peptic Ulcers Treatment Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Sihuan Pharmaceutical Holdings Group Ltd.
6.8.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Profiles
6.8.2 Sihuan Pharmaceutical Holdings Group Ltd. Product Introduction
6.8.3 Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Sinil Pharmaceutical Co., Ltd
6.9.1 Sinil Pharmaceutical Co., Ltd Company Profiles
6.9.2 Sinil Pharmaceutical Co., Ltd Product Introduction
6.9.3 Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Yooyoung Pharmaceutical Co., Ltd
6.10.1 Yooyoung Pharmaceutical Co., Ltd Company Profiles
6.10.2 Yooyoung Pharmaceutical Co., Ltd Product Introduction
6.10.3 Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
